title: Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth.
abstract: OBJECTIVE
  The aims of this study were to evaluate iodoform base materials for root canal treatment of necrotic primary teeth, and to compare them with traditionally used zinc oxide and eugenol (ZOE).
  
  
  METHODS
  Zinc oxide and eugenol and Vitapex (a premixed calcium hydroxide and iodoform paste) were compared for root canal treatment in 52 necrotic primary teeth in two groups of children with a mean age of 5 years and 8.4 months. All the patients were followed-up clinically and radiographically 3 months and 10-16 months postoperatively.
  
  
  RESULTS
  The overall success rates of Vitapex and ZOE were 100% and 78.5%, respectively. Using Fisher's Exact Test, the difference was statistically significant (P < 0.05).
  
  
  CONCLUSIONS
  Both ZOE and Vitapex gave encouraging results. Vitapex, however, can be used more safely whenever there is a doubt about the patient's return for follow-up.
authors.affiliation: Department of Paediatric Dentistry, School of Dental Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. mortazavi@sums.ac.ir
authors.forename: M
authors.initials: M
authors.lastname: Mortazavi
authors.forename: M
authors.initials: M
authors.lastname: Mesbahi
mesh_terms: D000293:Adolescent; D002126:Calcium Hydroxide / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003790:Dental Pulp Necrosis / Q000000981:diagnostic imaging / Q000628:therapy*; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008963:Molar / Q000000981:diagnostic imaging / Q000473:pathology; D010483:Periapical Diseases / Q000000981:diagnostic imaging / Q000628:therapy; D011672:Pulpotomy; D011859:Radiography; D012387:Root Canal Filling Materials / Q000627:therapeutic use*; D012390:Root Canal Therapy; D012828:Silicones / Q000627:therapeutic use*; D014094:Tooth, Deciduous / Q000000981:diagnostic imaging / Q000473:pathology*; D016896:Treatment Outcome; D015035:Zinc Oxide-Eugenol Cement / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; D012387:Root Canal Filling Materials; D012828:Silicones; D015035:Zinc Oxide-Eugenol Cement; C029584:calcium hydroxide, iodoform, silicone oil drug combination; D002126:Calcium Hydroxide